Growth Metrics

Regeneron Pharmaceuticals (REGN) EPS (Weighted Average and Diluted) (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -14.23%
Dec 31, 2025 -42.22%
Sep 30, 2025 6.32%
Jun 30, 2025 76.20%
Mar 31, 2025 -10.36%
Dec 31, 2024 -29.72%
Sep 30, 2024 -7.01%
Jun 30, 2024 97.93%
Mar 31, 2024 -38.53%
Dec 31, 2023 14.74%
Sep 30, 2023 4.59%
Jun 30, 2023 18.55%
Mar 31, 2023 -31.65%
Dec 31, 2022 -10.03%
Sep 30, 2022 56.09%
Jun 30, 2022 -13.24%
Mar 31, 2022 -56.25%
Dec 31, 2021 37.33%
Sep 30, 2021 -48.77%
Jun 30, 2021 177.21%
Mar 31, 2021 -1.46%
Dec 31, 2020 38.57%
Sep 30, 2020 -2.89%
Jun 30, 2020 40.15%
Mar 31, 2020 -21.65%
Dec 31, 2019 18.26%
Sep 30, 2019 248.81%
Jun 30, 2019 -57.89%
Mar 31, 2019 -44.20%
Dec 31, 2018 38.30%
Sep 30, 2018 7.26%
Jun 30, 2018 15.87%
Mar 31, 2018 177.33%
Dec 31, 2017 -54.82%
Sep 30, 2017 -0.60%
Jun 30, 2017 54.63%
Mar 31, 2017 -1.37%
Dec 31, 2016 -3.52%
Sep 30, 2016 34.32%
Jun 30, 2016 6.29%
Mar 31, 2016 18.66%
Dec 31, 2015 -26.37%
Sep 30, 2015 7.69%
Jun 30, 2015 156.06%
Mar 31, 2015 -15.38%
Dec 31, 2014 6.85%
Sep 30, 2014 -14.12%
Jun 30, 2014 39.34%
Mar 31, 2014 -29.07%
Dec 31, 2013 -31.20%
Sep 30, 2013 58.23%
Jun 30, 2013 -12.22%
Mar 31, 2013 -77.94%
Dec 31, 2012 137.21%
Sep 30, 2012 145.71%
Jun 30, 2012 536.36%
Mar 31, 2012 118.97%
Dec 31, 2011 14.71%
Sep 30, 2011 1.45%
Jun 30, 2011 -40.82%
Mar 31, 2011 -178.37%